- Home
- BGSF vs INO Comparison
BGSF vs INO Comparison
Compare BGSF & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGSF
- INO
- Stock Information
- Founded
- BGSF 2007
- INO 1979
- Country
- BGSF United States
- INO United States
- Employees
- BGSF N/A
- INO N/A
- Industry
- BGSF Professional Services
- INO Medical/Dental Instruments
- Sector
- BGSF Consumer Discretionary
- INO Health Care
- Exchange
- BGSF Nasdaq
- INO Nasdaq
- Market Cap
- BGSF 70.1M
- INO 69.3M
- IPO Year
- BGSF N/A
- INO 1998
- Fundamental
- Price
- BGSF $7.07
- INO $2.18
- Analyst Decision
- BGSF Strong Buy
- INO Buy
- Analyst Count
- BGSF 1
- INO 5
- Target Price
- BGSF $9.00
- INO $8.80
- AVG Volume (30 Days)
- BGSF 408.1K
- INO 2.1M
- Earning Date
- BGSF 11-05-2025
- INO 11-13-2025
- Dividend Yield
- BGSF N/A
- INO N/A
- EPS Growth
- BGSF N/A
- INO N/A
- EPS
- BGSF N/A
- INO N/A
- Revenue
- BGSF $266,615,000.00
- INO $182,337.00
- Revenue This Year
- BGSF N/A
- INO N/A
- Revenue Next Year
- BGSF N/A
- INO $15,960.33
- P/E Ratio
- BGSF N/A
- INO N/A
- Revenue Growth
- BGSF 28.60
- INO N/A
- 52 Week Low
- BGSF $2.91
- INO $1.30
- 52 Week High
- BGSF $9.06
- INO $7.00
- Technical
- Relative Strength Index (RSI)
- BGSF 59.80
- INO 47.09
- Support Level
- BGSF $6.36
- INO $2.33
- Resistance Level
- BGSF $8.22
- INO $2.98
- Average True Range (ATR)
- BGSF 0.32
- INO 0.20
- MACD
- BGSF 0.15
- INO -0.07
- Stochastic Oscillator
- BGSF 47.73
- INO 2.44
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.